The economic and workload impact of 'backdoor' prostate-specific antigen screening on the UK National Health Service: A single-centre experience

BJU International

Volumn 101, Issue 3, 2008, Pages 289-292

  Chelladurai, Arputharaj J ^a   Gunendran, Thiru ^a,b   Nicholson, Caroline ^a   Matanhelia, Shyam S ^a   Blades, Rosemary A ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Backdoor PSA screening; Costs; Economic impact

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; ECONOMIC ASPECT; HEALTH CARE FINANCING; HOSPITAL COST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SCREENING; UNITED KINGDOM;

AGED; BIOPSY, NEEDLE; COST OF ILLNESS; ENGLAND; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; WALES; WORKLOAD;

EID: 37849034935     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07311.x     Document Type: Article

References (14)

1. Office of National Statistics. Series MB1. No. 34. Registration of Cancer Diagnosed in 2003, England. London : Her Majesty s Stationary Office, 2005
2. Office of National Statistics. Series MB1. No. 30. Registration of Cancer Diagnosed in 1999, England. London : Her Majesty s Stationary Office, 2002
3. Office of National Statistics. Series MB1. No. 28. Registration of Cancer Diagnosed in 1995-97, England. London : Her Majesty s Stationary Office, 2001
4. Melia J, Hewitson P, Austoker J. Introduction. Review of screening for prostate cancer. BJU Int 2005 95 : 1 3
5. Department of Health. NHS Prostate Cancer Programme. London : DoH, 2000
6. Aus G, Abbou CC, Heidenreich A et al. Guidelines on Prostate Cancer. European Association of Urology Update 2003. Available at http://www.uroweb.org/ fileadmin/user_upload/Guidelines/2003_Prostate_Cancer_update.pdf Accessed August 2007
7. Department of Health. NHS reference costs 2003 and National tariff 2004. Payment by results core tools 2004. Available at http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070195 Accessed August 2007
8. Office of National Statistics. Series DH2. No. 31. Mortality Statistics. Review of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales, 2004. London : Her Majesty s Stationary Office, 2005
9. Gray JM. Population screening and patient testing using PSA. BJU Int 2005 95 (Suppl. 3 i
10. Chamberlain J, Melia J, Moss S, Brown J. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technol Assess 1997 1 : i vi, 1 53
11. Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate and bladder cancer in the UK. BJU Int 2005 95 : 59 63
12. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005 352 : 1977 84
13. Department of Health. The NHS Cancer Plan. London : DoH, 2000
14. Department of Health. Funding Boost for Prostate Cancer Awareness. Press release 2005/0374. London : DoH, 2005. Available at http://www.dh.gov.uk/en/ Publicationsandstatistics/Pressreleases/DH_4122228 Accessed August 2007.